Wegovy (Semaglutide) | WeightLossPills.com

At a Glance

Everything You Need to Know

Avg. Weight Loss

15%

Of starting body weight

Form & Schedule

Weekly Shot

Self-injected once per week

Food Restriction

None

Take any time, with or without food

Active Ingredient

Semaglutide

GLP-1 receptor agonist

Manufacturer

Novo Nordisk

Same maker as Ozempic & Oral Wegovy

FDA Status

✅ Approved

For chronic weight management

Plain English

What Exactly Is Wegovy?

A once weekly injection that reduces hunger and helps you eat less.Wegovy is a once-weekly injection that mimics a hormone your body naturally produces when you eat, helping you feel full faster and eat less.

Semaglutide, the active ingredient in Wegovy, is a lab-made version of GLP-1, a hormone your gut releases after you eat. GLP-1 signals your brain that you're full, slows digestion, and reduces the reward response to food. Wegovy delivers a higher dose than Ozempic (2.4 mg vs. up to 2 mg), and was specifically studied and approved for weight loss rather than diabetes.

You inject it once a week into your stomach, thigh, or upper arm using a simple auto-injector pen. Most people say the needle is nearly painless.

The Science, Simply

How Wegovy Works

It targets your brain and gut to reduce hunger without deprivation.Wegovy works on your brain and gut to reduce hunger and help you eat less without feeling deprived.

1

Mimics Your "Full" Hormone

Semaglutide binds to GLP-1 receptors in the brain and gut, sending a strong signal that you're satisfied. This happens even when you haven't eaten much, reducing total calorie intake naturally.

2

Slows Stomach Emptying

Food stays in your stomach longer after each meal, extending the feeling of fullness for hours. This is one of the main reasons people on Wegovy consistently eat smaller portions without trying.

3

Quiets Food Cravings

GLP-1 receptors in the brain's reward and appetite centers reduce cravings for high-calorie foods. Many users describe a dramatic reduction in "food noise," the constant mental preoccupation with eating.

Clinical Trial Data

What the Trials Showed

From the STEP trials: 4,500 participants, the largest GLP-1 study at the time.Wegovy's approval was based on the STEP clinical trial program, the largest GLP-1 weight loss trial ever conducted at that time, spanning over 4,500 participants.

15%

Average Body Weight Lost

STEP 1 trial over 68 weeks

1 in 3

Lost 20% or More

Compared to 1 in 14 on placebo

34 lbs

Average Pounds Lost

For a 230 lb person

ℹ️ Individual results vary. Trial participants also followed a reduced-calorie diet and increased physical activity. Most participants reached peak weight loss between weeks 60-68.

"The STEP trial numbers genuinely surprised me. Not because I doubted semaglutide but because 15 percent in a medical patient is what I'd expect from a sleeve. That made me rethink some conversations I was having with people who were on the fence about surgery."

Dr. Quoc N. Dang, DO

Bariatric Surgeon · Obesity Medicine

Eligibility

Is Wegovy Right for You?

Prescription only. For adults with obesity or a weight related condition.Wegovy requires a prescription and is intended for adults with obesity or overweight with at least one weight-related health condition.

✅ Good Candidates

BMI of 30 or higher (clinically obese)
BMI of 27+ with a weight-related condition (type 2 diabetes, high blood pressure, high cholesterol)
Adults comfortable with a weekly self-injection
People who want the most extensively studied GLP-1 for weight loss
Those who prefer not to take a daily pill

⚠️ May Not Be Right If...

You have a personal or family history of thyroid cancer (MTC)
You have Multiple Endocrine Neoplasia syndrome type 2
You're pregnant, planning to become pregnant, or breastfeeding
You have a history of pancreatitis or serious kidney disease
You're already taking another GLP-1 medication (like Ozempic)

⚕️ Always consult your doctor before starting any weight loss medication.

What to Expect

Side Effects

Mostly GI related and short lived. A slow dose ramp helps minimize them.Most side effects are gastrointestinal and improve as your body adjusts over the first 4 to 8 weeks. Wegovy uses a gradual dose escalation schedule specifically to reduce these early symptoms.

Common Side Effects

Usually mild to moderate · Often improve over time

Nausea44%
Diarrhea30%
Vomiting24%
Constipation24%
Stomach pain20%
Decreased appetite19%

Serious (Rare) Side Effects

Uncommon · Contact your doctor immediately

Severe abdominal pain (possible pancreatitis)
Thyroid tumors (rare, seen in animal studies)
Gallbladder problems (gallstones)
Kidney issues (often from dehydration)
Increased heart rate

Pricing & Access

What Does Wegovy Cost?

High list price but savings programs make it reachable for many patients.Wegovy's list price is high, but savings programs make it accessible for many patients, especially those with commercial insurance.

Self-Pay (No Insurance)

~$349/mo

Through NovoCare or pharmacy savings programs. List price is much higher; most patients access lower rates through patient savings programs.

With Commercial InsuranceAs low as $25/mo
Novo Nordisk's My $25 WeGoHealth savings program for eligible commercially insured patients.

Medicare / Medicaid

Varies

Coverage improving under recent legislation. Check with your plan directly, as coverage can vary significantly by state and plan type.

💡 Tip: Check Novo Nordisk's official savings program at wegovy.com. Many commercially insured patients pay $25/month or less. NovoCare can also help uninsured or underinsured patients find lower-cost options.

Side by Side

Wegovy vs. Other Options

Wegovy vs. the other leading weight loss medications.How does Wegovy stack up against the other leading weight loss medications?

Medication	Avg. Weight Loss	Form	Food Restriction	Approved For
💉Wegovy You're here	15%	Weekly Injection	None ✓	Weight Loss
💉Zepbound	21%	Weekly Injection	None ✓	Weight Loss
💊Foundayo	9-15%	Daily Pill	None ✓	Weight Loss
💊Oral Wegovy	15%	Daily Pill	Empty stomach	Weight Loss

Common Questions

Frequently Asked Questions

Most people describe the injection as nearly painless. Wegovy uses a very thin needle (32 gauge) that is barely felt. The auto-injector pen is designed to be easy to use. You inject into the fatty tissue of your stomach, thigh, or upper arm. Some mild stinging at the injection site can occur, but serious pain is uncommon.

Both contain semaglutide, but Wegovy is approved specifically for weight loss at a higher maximum dose of 2.4 mg per week. Ozempic is approved for type 2 diabetes at doses up to 2 mg per week. While some doctors prescribe Ozempic off-label for weight loss, Wegovy's higher dose consistently produces greater weight loss results in clinical trials.

Wegovy is intended as a long-term treatment. Studies show that most people regain a significant portion of lost weight within 12 months of stopping. Many doctors consider GLP-1 medications like Wegovy to be similar to blood pressure medication, something you take consistently to manage a chronic condition. Talk to your doctor about a long-term plan before starting.

Coverage varies widely. Many commercial insurance plans cover Wegovy for patients who meet the eligibility criteria (BMI 30+, or BMI 27+ with a weight-related condition). Medicare and Medicaid coverage has been expanding under recent legislation. Novo Nordisk's savings program allows eligible commercially insured patients to pay as little as $25 per month. Always check your specific plan details.

Wegovy is an injection while newer options like Foundayo and Oral Wegovy are daily pills. Injection-based semaglutide delivers the drug directly into the bloodstream very efficiently. The oral versions require specific delivery strategies to achieve absorption. All three have shown similar average weight loss results (15%), but Zepbound (a different drug, tirzepatide) shows higher average results at 21%.

Wegovy